Researchers validate the REDMOD AI framework, which detects early, otherwise invisible, tissue changes of pancreatic cancer on CT scans before clinical diagnosis.
Key Details
- 1REDMOD is an AI radiomics model for detecting subtle texture changes indicative of stage 0 pancreatic ductal adenocarcinoma on CT.
- 2The model identified preclinical disease an average of 475 days before clinical diagnosis.
- 3In head-to-head comparison, REDMOD's sensitivity was nearly double that of expert radiologists (73% vs. 39%).
- 4Performance remained high (68% vs. 23%) for cancers detected over two years before diagnosis.
- 5The model showed strong generalisability in external cohorts (correctly identifying >81% and 87.5% of cases in independent datasets).
- 6Researchers caution further prospective validation and testing in high-risk patients are needed before clinical adoption.
Why It Matters
Ultra-early detection of pancreatic cancer could dramatically improve survival rates by enabling treatment before symptoms arise. AI models like REDMOD may soon provide radiologists with powerful new tools to catch deadly cancers in their most treatable phases.
Source
EurekAlert
Related News
•EurekAlert
AI System Enhances Cancer Cell Detection via Light Scattering Spectra
Japanese researchers developed an AI system using light scattering spectra to improve cancer cell identification in cytology.
•EurekAlert
AI and X-ray Imaging Reveal Lost Texts in Ancient Roman Scrolls
AI and x-ray technology enable scientists to virtually read previously unreadable, carbonized Roman scrolls from Herculaneum.
•EurekAlert
AI’s Potential to Expand, Not Shrink, the Clinical Workforce
AI advancements may lead to more, not fewer, healthcare jobs, challenging common fears about workforce reductions in specialties like radiology.